Steven R. Cox

Safety, pharmacokinetics and use of the novel NK‐1 receptor antagonist maropitant (Cerenia^TM) for the prevention of emesis and motion sickness in cats

M. Anne Hickman, Steven R. Cox, Sean P. Mahabir et al. · Journal of Veterinary Pharmacology and Therapeutics · 2008 · 117 citations

Sc Administration, Pharmacological Study, Medicine +11

The pharmacokinetics of mavacoxib, a long‐acting COX‐2 inhibitor, in young adult laboratory dogs

Steven R. Cox, S. P. LESMAN, Joseph F. Boucher et al. · Journal of Veterinary Pharmacology and Therapeutics · 2010 · 92 citations

Animal Physiology, Veterinary Physiology, Pharmacokinetic Modeling +13

Correlations between gluten aggregation properties defined by the GlutoPeak test and content of quality-related protein fractions of winter wheat flour

Alessandra Marti, Elliot Augst, Steven R. Cox et al. · Journal of Cereal Science · 2015 · 79 citations · Full text

Food Chemistry, Gluten-free Nutrition, Gluten Aggregation Properties +7

The pharmacokinetics of maropitant, a novel neurokinin type‐1 receptor antagonist, in dogs

H. A. Benchaoui, Steven R. Cox, Richard Schneider et al. · Journal of Veterinary Pharmacology and Therapeutics · 2007 · 75 citations · Full text

Neuropeptides, Oral Bioavailability, Pharmacological Study +11

Steady-state pharmacokinetics of delavirdine in HIV-positive patients: Effect on erythromycin breath test *

Ching‐Ling Cheng, David E. Smith, Peggy L. Carver et al. · Clinical Pharmacology & Therapeutics · 1997 · 61 citations · Full text